PathAI Announces PLUTO: a State-of-the-art Foundation Model to Enhance AI-powered Pathology Tools
Tissuepathology
by Erica Goodpaster
5d ago
PathAI: Foundation models were developed on numerous diverse data and will enable drug discovery and anatomic pathology laboratory use cases BOSTON, MA / ACCESSWIRE / May 14, 2024 / PathAI, a global leader in AI-powered pathology, today announced the launch of Pathology Universal Transformer (PLUTO), a pathology-centric foundation model, to further differentiate their portfolio of products geared towards […] The post PathAI Announces PLUTO: a State-of-the-art Foundation Model to Enhance AI-powered Pathology Tools first appeared on Tissuepathology.com ..read more
Visit website
Indica Labs Announces Masterclass Webinar
Tissuepathology
by Erica Goodpaster
1w ago
Indica Labs: Learn the latest in highly multiplexed image analysis with HALO Masterclass Webinar: Performing Highly Multiplexed IF and Spatial Analysis Workflows with HALO® Date: 25 June 2024 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 – 17:00 BST Location: Webinar Register Now Summary Join us for this 1-hour webinar to see a live demonstration of […] The post Indica Labs Announces Masterclass Webinar first appeared on Tissuepathology.com ..read more
Visit website
The Pathology Job Market Post–COVID-19—Where Are We Now? A Comparison of Pathology Job Advertisements From 2013–2017 to 2018–2022
Tissuepathology
by Erica Goodpaster
1w ago
Debra L. Zynger, MS, MD;  Nat Pernick, MD Arch Pathol Lab Med (2023) 147 (11): 1227–1228. https://doi.org/10.5858/arpa.2023-0211-LE To the Editor.—The pathology job market in the United States has been a source of concern, controversy, and confusion. There is a paucity of data on the job market, with information predominately from surveys of graduating trainees and pathologists […] The post The Pathology Job Market Post–COVID-19—Where Are We Now? A Comparison of Pathology Job Advertisements From 2013–2017 to 2018–2022 first appeared on Tissuepathology.com ..read more
Visit website
Indica Labs Announces June Webinar
Tissuepathology
by Erica Goodpaster
1w ago
Indica Labs: Learn how the 510(k)-cleared HALO AP Dx platform can be used for comprehensive workflows in primary diagnostics Introducing HALO AP Dx: An Enterprise Pathology Platform for Primary Diagnosis Date: 13 June 2024 Time: 8:00 – 9:00 PDT | 11:00 – 12:00 EDT | 16:00 – 17:00 BST Location: Webinar Register Now Summary Attend this 1-hour webinar to see a […] The post Indica Labs Announces June Webinar first appeared on Tissuepathology.com ..read more
Visit website
Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform
Tissuepathology
by Erica Goodpaster
1w ago
Indica Labs: HALO AP Dx brings digital primary diagnosis to anatomic pathology labs in the US. ALBUQUERQUE, NM / ACCESSWIRE / May 8, 2024 / Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA clearance for HALO AP Dx, an enterprise digital pathology platform, for primary diagnosis. This 510(k) clearance allows […] The post Indica Labs Receives First FDA Clearance for HALO AP Dx Digital Pathology Platform first appeared on Tissuepathology.com ..read more
Visit website
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Tissuepathology
by Erica Goodpaster
1w ago
Deciphera Shareholders to Receive $25.60 per Share in Cash Deciphera’s Kinase Inhibitor Expertise and Established Commercialization Platform in Key Markets Will Reinforce ONO Pharmaceutical’s Pipeline and Accelerate Global Reach WALTHAM, Mass.–(BUSINESS WIRE)–Apr. 29, 2024– Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, […] The post Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion first appear ..read more
Visit website
Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI
Tissuepathology
by Erica Goodpaster
2w ago
PathAI: Transaction is part of wide-ranging collaboration to combine Quest’s oncology expertise and scale with PathAI’s AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs  SECAUCUS, N.J. and BOSTON – May 1, 2024 – Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered […] The post Quest Diagnostics to Acquire PathAI Diagnostics to Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements with PathAI first appeared on Tissuepatholog ..read more
Visit website
Aiosyn’s AI-powered mitosis detection solution is now accessible in Sectra Amplifier Marketplace
Tissuepathology
by Erica Goodpaster
2w ago
Nijmegen, the Netherlands – Aiosyn, a pioneering medical software company specializing in AI-powered pathology solutions for cancer and kidney diseases, has announced the integration of its innovative mitosis detection algorithm, Aiosyn Mitosis Breast*, with Sectra’s solution for digital pathology. It is now part of the Sectra Amplifier Marketplace. This allows pathology laboratories worldwide using Sectra’s […] The post Aiosyn’s AI-powered mitosis detection solution is now accessible in Sectra Amplifier Marketplace first appeared on Tissuepathology.com ..read more
Visit website
Join Cytomine in Vilnius for ECDP 2024
Tissuepathology
by Erica Goodpaster
2w ago
From Cytomine: JOIN US IN VILNIUS FOR ECDP 2024 We are excited to invite you to the 20th European Conference on Digital Pathology (ECDP) in Vilnius, Lithuania. Why you should attend We will be delighted to welcome you at our stand to discuss Cytomine Enterprise Editions solutions new features and future evolutions and answer all […] The post Join Cytomine in Vilnius for ECDP 2024 first appeared on Tissuepathology.com ..read more
Visit website
Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM
Tissuepathology
by Erica Goodpaster
3w ago
Leica Biosystems is pleased to announce that its flagship digital pathology system, Aperio GT 450 DX, has  received 510(k) clearance from the US Food and Drug Administration. Previously sold into the clinical market under an enforcement discretion due to the COVID-19 pandemic, Aperio GT 450 is proven technology that consistently delivers high-quality images at a […] The post Leica Biosystems Receives FDA 510(k) Clearance for Aperio GT 450 DX Digital Pathology System with both SVS and Native DICOM first appeared on Tissuepathology.com ..read more
Visit website

Follow Tissuepathology on FeedSpot

Continue with Google
Continue with Apple
OR